Overview
SCIENTIFIC SCORE
Questionable
Based on 17 Researches
5.9
USERS' SCORE
Moderately Good
Based on 2 Reviews
7.4
Supplement Facts
Serving Size: 2 Soft Gels
Amount Per Serving
%DV
Calories
30
Total Fat
2.5 g
3%**
Cholesterol
<5 mg
1%
Protein
<1 g
Vitamin E (as natural d-alpha tocopherol)
13.4 mg
89%
Norwegian Fish Oil
2.5 g
â€
Total Omega-3 Fatty Acids*
1,600 mg
â€
EPA (Eicosapentaenoic Acid)*
800 mg
â€
DHA (Docosahexaenoic Acid)*
600 mg
â€
Top Medical Research Studies
We examined whether taking omega-3 fatty acids could enhance the effects of dual antiplatelet therapy for patients dealing with stable angina after heart procedures. Our study involved 40 patients who were split into two groups: one received omega-3 alongside standard medication, while the other did not.
After testing platelet activity over time, we found no significant differences between the two groups. This suggests that omega-3 fish oil does not provide additional benefits for managing chest pain in these patients.
After testing platelet activity over time, we found no significant differences between the two groups. This suggests that omega-3 fish oil does not provide additional benefits for managing chest pain in these patients.
Read More
8
We explored the effects of low-dose fish oil concentrate on patients experiencing angina due to coronary artery disease. In a study with 39 patients, one group received fish oil while the other was given a placebo.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Read More
8
We conducted a trial involving 23 geriatric patients to see if low-dose fish oil could help with angina pectoris.
Using a single-blind, placebo-controlled, crossover design, we discovered that fish oil significantly reduced the number of anginal attacks and the need for sublingual isosorbide dinitrate tablets.
Additionally, there seemed to be a lingering effect of fish oil even after switching to the placebo, suggesting potential long-term benefits.
Using a single-blind, placebo-controlled, crossover design, we discovered that fish oil significantly reduced the number of anginal attacks and the need for sublingual isosorbide dinitrate tablets.
Additionally, there seemed to be a lingering effect of fish oil even after switching to the placebo, suggesting potential long-term benefits.
Read More
Most Useful Reviews
2
Stomach pain noted
1 people found this helpful
I regularly take omega 3 and ordered this for its reasonable price and positive reviews. Unfortunately, after ten days, I experienced significant stomach pain, which I had not encountered before. I also had a constant citrus-flavoured burp. While the capsules were easy to swallow and odourless, I did not find the product satisfactory.
Read More
2
Consistent stomach pain
This supplement caused me stomach pain regardless of whether I took it with food or after eating. The pain only subsided after I stopped taking it.
Read More
Medical Researches
SCIENTIFIC SCORE
Questionable
Based on 17 Researches
5.9
- All Researches
8
We investigated whether adding eicosapentaenoic acid (EPA), an omega-3 fatty acid, to statin therapy could help reduce chest pain linked to coronary heart disease. In this randomized controlled trial involving 193 patients, those taking both EPA and pitavastatin experienced a significant reduction in coronary plaque volume compared to those on statins alone.
While the combination therapy particularly benefited patients with stable angina, it did not reduce major cardiovascular events or side effects. This suggests that while EPA may enhance plaque stability, it does not necessarily lower chest pain symptoms in all cases.
While the combination therapy particularly benefited patients with stable angina, it did not reduce major cardiovascular events or side effects. This suggests that while EPA may enhance plaque stability, it does not necessarily lower chest pain symptoms in all cases.
Read More
8
Fish oil reduces cardiac events
We examined the effects of fish oil on chest pain in a randomized trial involving 360 patients experiencing suspected acute myocardial infarction.
After one year, we found that those taking fish oil had significantly fewer cardiac events and nonfatal infarctions compared to the placebo group.
Interestingly, while fish oil appeared to lower cardiac death rates, mustard oil showed no similar benefit.
Overall, this suggests that fish oil may offer protective effects, though more extensive research is needed for confirmation.
After one year, we found that those taking fish oil had significantly fewer cardiac events and nonfatal infarctions compared to the placebo group.
Interestingly, while fish oil appeared to lower cardiac death rates, mustard oil showed no similar benefit.
Overall, this suggests that fish oil may offer protective effects, though more extensive research is needed for confirmation.
Read More
8
We explored the effects of low-dose fish oil concentrate on patients experiencing angina due to coronary artery disease. In a study with 39 patients, one group received fish oil while the other was given a placebo.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Remarkably, we observed that the fish oil group experienced a 41% reduction in anginal attacks and a significant decrease in medication use over the treatment period. They also enjoyed longer exercise tolerance times and lower serum triglycerides.
Conversely, the placebo group showed no significant changes. Our findings suggest that low-dose fish oil may indeed benefit those struggling with chest pain.
Read More
8
We conducted a trial involving 23 geriatric patients to see if low-dose fish oil could help with angina pectoris.
Using a single-blind, placebo-controlled, crossover design, we discovered that fish oil significantly reduced the number of anginal attacks and the need for sublingual isosorbide dinitrate tablets.
Additionally, there seemed to be a lingering effect of fish oil even after switching to the placebo, suggesting potential long-term benefits.
Using a single-blind, placebo-controlled, crossover design, we discovered that fish oil significantly reduced the number of anginal attacks and the need for sublingual isosorbide dinitrate tablets.
Additionally, there seemed to be a lingering effect of fish oil even after switching to the placebo, suggesting potential long-term benefits.
Read More
8
We examined the long-term effects of a fish lipid concentrate high in eicosapentaenoic acid in 107 subjects, some with heart conditions and others without. Over two years, we noticed marked reductions in triglycerides, a mild decrease in total cholesterol, and an increase in HDL cholesterol.
Notably, we found a significant decrease in the use of GTN tablets, correlating with fewer angina attacks. This suggests that omega-3 may help enhance heart health by reducing symptoms and improving lipid profiles, although bleeding times also increased.
Notably, we found a significant decrease in the use of GTN tablets, correlating with fewer angina attacks. This suggests that omega-3 may help enhance heart health by reducing symptoms and improving lipid profiles, although bleeding times also increased.
Read More
User Reviews
USERS' SCORE
Moderately Good
Based on 2 Reviews
7.4
- All Reviews
- Positive Reviews
- Negative Reviews
2
Stomach pain noted
1 people found this helpful
I regularly take omega 3 and ordered this for its reasonable price and positive reviews. Unfortunately, after ten days, I experienced significant stomach pain, which I had not encountered before. I also had a constant citrus-flavoured burp. While the capsules were easy to swallow and odourless, I did not find the product satisfactory.
Read More
2
Consistent stomach pain
This supplement caused me stomach pain regardless of whether I took it with food or after eating. The pain only subsided after I stopped taking it.
Read More
Frequently Asked Questions
No FAQs are available for this product and symptom.
References
- Irfan A, Haider SH, Nasir A, Larik MO, Naz T. Assessing the Efficacy of Omega-3 Fatty Acids + Statins vs. Statins Only on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis of 40,991 Patients. Curr Probl Cardiol. 2024;49:102245. doi:10.1016/j.cpcardiol.2023.102245
- Tawara K, Akioka H, Sato H, Sato T, Takahashi M, et al. Role of polyunsaturated fatty acids in Japanese patients with coronary spastic angina. J Cardiol. 2023;82:455. doi:10.1016/j.jjcc.2023.07.001
- Watanabe T, Ando K, Daidoji H, Otaki Y, Sugawara S, et al. A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins. J Cardiol. 2017;70:537. doi:10.1016/j.jjcc.2017.07.007
- Gajos G, Zalewski J, Mostowik M, Konduracka E, Nessler J, et al. Polyunsaturated omega-3 fatty acids reduce lipoprotein-associated phospholipase A(2) in patients with stable angina. Nutr Metab Cardiovasc Dis. 2014;24:434. doi:10.1016/j.numecd.2013.09.011
- Mizia-Stec K, Mizia M, Haberka M, Lasota B, Gieszczyk-Strózik K, et al. N-3 polyunsaturated fatty acids do not influence the efficacy of dual antiplatelet therapy in stable angina pectoris patients after percutaneous coronary intervention. Cardiol J. 2013;20:478. doi:10.5603/CJ.2013.0132
- Zhao YT, Chen Q, Sun YX, Li XB, Zhang P, et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Ann Med. 2009;41:301. doi:10.1080/07853890802698834
- Singh RB, Niaz MA, Sharma JP, Kumar R, Rastogi V, et al. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4. Cardiovasc Drugs Ther. 1997;11:485.
- Yamamoto H, Yoshimura H, Noma M, Suzuki S, Kai H, et al. Improvement of coronary vasomotion with eicosapentaenoic acid does not inhibit acetylcholine-induced coronary vasospasm in patients with variant angina. Jpn Circ J. 1995;59:608.
- Salachas A, Papadopoulos C, Sakadamis G, Styliadis J, Voudris V, et al. Effects of a low-dose fish oil concentrate on angina, exercise tolerance time, serum triglycerides, and platelet function. Angiology. 1994;45:1023.
- Aucamp AK, Schoeman HS, Coetzee JH. Pilot trial to determine the efficacy of a low dose of fish oil in the treatment of angina pectoris in the geriatric patient. Prostaglandins Leukot Essent Fatty Acids. 1993;49:687.
- Kalinkina OM, GratsianskiÄ NA, Perova NV, Metel'skaia VA, Zykova VP, et al. [Newly developed stenocardia: effect of diet with increased amount of polyunsaturated fatty acids of the omega-3 group on blood lipids and apolipoproteins]. Kardiologiia. 1990;30:34.
- Kalinkina OM, Perova NV, Zykova VP, GratsianskiÄ NA, Mel'kina OE, et al. [The effect of a diet enriched with omega-3 polyunsaturated fatty acids on thrombocyte functional activity and on the blood lipid-apolipoprotein spectrum in newly occurring stenocardia]. Ter Arkh. 1990;62:77.
- Solomon SA, Cartwright I, Pockley G, Greaves M, Preston FE, et al. A placebo-controlled, double-blind study of eicosapentaenoic acid-rich fish oil in patients with stable angina pectoris. Curr Med Res Opin. 1990;12:1.
- Saynor R, Verel D, Gillott T. The long-term effect of dietary supplementation with fish lipid concentrate on serum lipids, bleeding time, platelets and angina. Atherosclerosis. 1984;50:3.
- Zykova VP, Perova NV, Kalinkina OM. [Study of in vitro thromboxane A2 generation by platelets of patients with first-time appearing angina pectoris under the effect of fish diet]. Kardiologiia. 1990;30:24.
- Schmidt EB, Kristensen SD, Dyerberg J. The effect of fish oil on lipids, coagulation and fibrinolysis in patients with angina pectoris. Artery. 1988;15:316.
- Kondo T, Ogawa K, Satake T, Kitazawa M, Taki K, et al. Plasma-free eicosapentaenoic acid/arachidonic acid ratio: a possible new coronary risk factor. Clin Cardiol. 1986;9:413.
